Details for New Drug Application (NDA): 021359
✉ Email this page to a colleague
The generic ingredient in RECTIV is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 021359
Tradename: | RECTIV |
Applicant: | Abbvie |
Ingredient: | nitroglycerin |
Patents: | 0 |
Pharmacology for NDA: 021359
Physiological Effect | Vasodilation |
Medical Subject Heading (MeSH) Categories for 021359
Suppliers and Packaging for NDA: 021359
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RECTIV | nitroglycerin | OINTMENT;INTRA-ANAL | 021359 | NDA | Allergan, Inc. | 58914-301 | 58914-301-80 | 1 TUBE in 1 CARTON (58914-301-80) / 30 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;INTRA-ANAL | Strength | 0.4% | ||||
Approval Date: | Jun 21, 2011 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021359
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | RECTIV | nitroglycerin | OINTMENT;INTRA-ANAL | 021359-001 | Jun 21, 2011 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription